Emerik Österlund

556 total citations
14 papers, 146 citations indexed

About

Emerik Österlund is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Emerik Österlund has authored 14 papers receiving a total of 146 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 6 papers in Pathology and Forensic Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Emerik Österlund's work include Colorectal Cancer Treatments and Studies (12 papers), Genetic factors in colorectal cancer (6 papers) and Gastric Cancer Management and Outcomes (5 papers). Emerik Österlund is often cited by papers focused on Colorectal Cancer Treatments and Studies (12 papers), Genetic factors in colorectal cancer (6 papers) and Gastric Cancer Management and Outcomes (5 papers). Emerik Österlund collaborates with scholars based in Sweden, Finland and United States. Emerik Österlund's co-authors include Bengt Glimelius, Israa Imam, Erik Osterman, Klara Hammarström, Tobias Sjöblom, Soili Kytölä, Kristiina Aittomäki, Anna‐Kaisa Anttonen, Leena‐Maija Soveri and Ari Ristimäki and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Oncology.

In The Last Decade

Emerik Österlund

10 papers receiving 144 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Emerik Österlund Sweden 5 103 64 46 32 26 14 146
Jesper Nors Denmark 7 105 1.0× 62 1.0× 37 0.8× 41 1.3× 26 1.0× 15 175
José Luis Manzano Mozo Spain 5 155 1.5× 38 0.6× 46 1.0× 33 1.0× 23 0.9× 15 176
Iris van ’t Erve Netherlands 6 78 0.8× 99 1.5× 66 1.4× 45 1.4× 25 1.0× 12 143
Cosimo Rasola Italy 7 88 0.9× 37 0.6× 48 1.0× 26 0.8× 13 0.5× 16 118
Nieves Martínez Lago Spain 8 121 1.2× 33 0.5× 29 0.6× 51 1.6× 40 1.5× 44 165
Ayman Zawadi France 5 101 1.0× 25 0.4× 76 1.7× 28 0.9× 9 0.3× 13 132
Hiroki Yukami Japan 6 92 0.9× 104 1.6× 85 1.8× 51 1.6× 24 0.9× 20 152
Ross A. Miller United States 8 49 0.5× 31 0.5× 22 0.5× 33 1.0× 20 0.8× 14 150
Elisa Vink‐Börger Netherlands 7 60 0.6× 38 0.6× 38 0.8× 27 0.8× 39 1.5× 13 124
J.-F. Emile France 4 77 0.7× 24 0.4× 24 0.5× 61 1.9× 63 2.4× 5 133

Countries citing papers authored by Emerik Österlund

Since Specialization
Citations

This map shows the geographic impact of Emerik Österlund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emerik Österlund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emerik Österlund more than expected).

Fields of papers citing papers by Emerik Österlund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emerik Österlund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emerik Österlund. The network helps show where Emerik Österlund may publish in the future.

Co-authorship network of co-authors of Emerik Österlund

This figure shows the co-authorship network connecting the top 25 collaborators of Emerik Österlund. A scholar is included among the top collaborators of Emerik Österlund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emerik Österlund. Emerik Österlund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Österlund, Emerik, Andrew J. Pellatt, Christine M. Parseghian, et al.. (2025). 732MO Circulating tumour DNA (ctDNA) clearance and correlation with outcome in the INTERCEPT colorectal cancer (CRC) study. Annals of Oncology. 36. S480–S480. 1 indexed citations
2.
Österlund, Pia, Timo Muhonen, Emerik Österlund, et al.. (2025). Relapse patterns, risk factors, re-resectability and survival after curative treatment for metastatic colorectal cancer (mCRC): A RAXO substudy.. Journal of Clinical Oncology. 43(16_suppl). 3566–3566.
3.
Österlund, Emerik, Klara Hammarström, Luís Nunes, et al.. (2025). Primary tumour location, molecular alterations, treatments, and outcome in a population-based metastatic colorectal cancer cohort. PubMed. 3(1). 38–38.
4.
Österlund, Emerik, Andrew J. Pellatt, Christine M. Parseghian, et al.. (2025). Biologic correlates of circulating tumor DNA (ctDNA) shedding in the INTERCEPT colorectal cancer (CRC) study.. Journal of Clinical Oncology. 43(16_suppl). 3591–3591. 1 indexed citations
5.
Hammarström, Klara, Luís Nunes, Lucy Mathot, et al.. (2024). Clinical and genetic factors associated with tumor response to neoadjuvant (chemo)radiotherapy, survival and recurrence risk in rectal cancer. International Journal of Cancer. 155(1). 40–53. 6 indexed citations
6.
7.
Heervä, Eetu, Ari Ristimäki, Soili Kytölä, et al.. (2023). PD-19 Finnish population-based metastatic colorectal cancer data collection study – comparison with the prospective RAXO study. Annals of Oncology. 34. S8–S9.
8.
Weibull, Caroline E., G. Palmer, Emerik Österlund, et al.. (2022). Sex differences in metastatic surgery following diagnosis of synchronous metastatic colorectal cancer. International Journal of Cancer. 152(3). 363–373. 7 indexed citations
9.
10.
Osterman, Erik, Klara Hammarström, Israa Imam, et al.. (2021). Completeness and accuracy of the registration of recurrences in the Swedish Colorectal Cancer Registry (SCRCR) and an update of recurrence risk in colon cancer. Acta Oncologica. 60(7). 842–849. 23 indexed citations
11.
12.
13.
Holm, Matilda, Emma Andersson, Emerik Österlund, et al.. (2020). Detection of KRAS mutations in liquid biopsies from metastatic colorectal cancer patients using droplet digital PCR, Idylla, and next generation sequencing. PLoS ONE. 15(11). e0239819–e0239819. 62 indexed citations
14.
Osterman, Erik, Klara Hammarström, Israa Imam, et al.. (2020). Recurrence Risk after Radical Colorectal Cancer Surgery—Less Than before, But How High Is It?. Cancers. 12(11). 3308–3308. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jesper Nors Breakdown of academic impact, for papers by José Luis Manzano Mozo Breakdown of academic impact, for papers by Iris van ’t Erve Breakdown of academic impact, for papers by Cosimo Rasola Breakdown of academic impact, for papers by Nieves Martínez Lago Breakdown of academic impact, for papers by Ayman Zawadi Breakdown of academic impact, for papers by Hiroki Yukami Breakdown of academic impact, for papers by Ross A. Miller Breakdown of academic impact, for papers by Elisa Vink‐Börger Breakdown of academic impact, for papers by J.-F. Emile
Rankless by CCL
2026